Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Chinese Pharmacopoeia 2010 Edition To Raise Standards

This article was originally published in PharmAsia News

Executive Summary

Chinese Pharmacopoeia, the gold standard for medicine in China, has begun revising its contents. The 2010 edition will extend the record of chemical pharmaceuticals and TCM, adjust the standards of pharmaceutical technology and prepare a catalog of newly added drugs. The revised draft will be completed before the end of 2008. The pharmaceutical industry subscribes to the standards in Chinese Pharmacopoeia as the minimum basis for the quality of all drugs and production technology. With the Chinese authority's stricter supervision of adverse drug reactions, the revision is set to raise the standards for drug quality. (Click here for more - Chinese Language)

You may also be interested in...

Revised Pharmacopoeia 2010 Edition Focuses On Standardization

The 9th Chinese Pharmacopoeia Commission, established in 2007, recently held a working meeting to discuss the revision of Chinese Pharmacopoeia 2010 edition (PharmAsia News, Feb. 4, 2008). The new directory will focus on raising the standards of TCM, biochemical drugs and injections. The revision will modify those drugs with weak standards or whose methodology cannot be duplicated, as well as eliminate drugs which are not applicable in clinical practice or which have quality control or potential safety risks. A separate injection drug commission will be in charge of collecting injection data and understanding existing problems based on specific subjects such as TCM, antibiotics and biological products. The commission hopes that suggestions contributed will help conceptualize a basic platform for the field. (Click here for more - Chinese Language)

What To Consider For German Orphan Drug Price Negotiations

The German pricing and reimbursement system has been successful in recognizing the value and uniqueness of orphan drugs.

Viatris’ UpJohn Breaking Taboo Around Erectile Dysfunction With UK PR Campaign

Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals. 




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts